Neoadjuvant Chemoradiation in Squamous Cell Carcinoma of the Maxillary Sinus: A 26-Year Experience

Table 1

Patient and tumor characteristics.

Patients n	53
Age (years)
Mean ± standard deviation	57.9 ± 11.3
Median	58.0
Minimum/maximum	18/78
Gender n (%)
Male	41 (77.4%)
Female	12 (22.6%)
cT-classification n (%)
T2	3 (5.7%)
T3	11 (20.8%)
T4a	34 (64.1%)
T4b	5 (9.4%)
cN-classification n (%)
N0	28 (52.8%)
N1	6 (11.3%)
N2	19 (35.8%)
UICC stage grouping n (%)
II	2 (3.8%)
III	10 (18.9%)
IVa	36 (67.9%)
IVb	5 (9.4%)
Complete response (CR) n (%)
No	42 (79.2%)
Yes	11 (20.8%)
Orbital infiltration n (%)
No	11 (20.8%)
Yes	42 (79.2%)
Relapse n (%)
No	35 (66.0%)
Yes	18 (34.0%)
Radiotherapy n (%)
40 Gy	18 (34.0%)
50 Gy	35 (66.0%)
Chemotherapy n (%)
Carboplatin	20 (37.7%)
Cisplatin	33 (62.3%)